Subdivision and Bonus of Equity Shares of Anlon Healthcare Ltd (Scrip Code: 544497)

Description

BSE notifies a record date of 24 April 2026 for Anlon Healthcare Ltd's equity share subdivision (10:1, face value Rs.10 to Rs.2) and a 1:1 bonus issue of the new Rs.2 shares.

Summary

BSE has notified trading members that Anlon Healthcare Ltd (Scrip Code: 544497) has fixed 24 April 2026 as the Record Date for a simultaneous equity share subdivision and bonus issue. Each existing Rs.10 share will be split into ten Rs.2 shares, and one additional Rs.2 bonus share will then be issued for every Rs.2 share held. Approximately 26,57,57,500 equity shares are expected to be allotted on 27 April 2026.

Key Points

• Record Date: 24 April 2026
• Subdivision ratio: 1 equity share of Rs.10/- face value → 10 equity shares of Rs.2/- face value
• Bonus ratio: 1 bonus equity share of Rs.2/- for every 1 equity share of Rs.2/- held (i.e., 1:1 post-split)
• Allotment date: 27 April 2026 (26,57,57,500 shares to be allotted)
• Existing ISIN INE0Y8W01017 (Rs.10/- paid-up) will be invalid for exchange transactions on or after 24 April 2026
• A new ISIN for the Rs.2/- paid-up shares will be communicated via a separate notice
• Reference: DR-617/2026-2027

Regulatory Changes

No new regulations introduced. The notice is an operational corporate-action notification under BSE Listing Operations procedures, informing the market of the ISIN transition and effective dates.

Compliance Requirements

• Trading members must cease using ISIN INE0Y8W01017 for exchange transactions from 24 April 2026 onward
• Members should await the separate BSE notice announcing the new ISIN for the Rs.2/- paid-up shares before executing post-record-date trades
• Depository participants and custodians should update client holdings to reflect the subdivision and bonus allotment effective 27 April 2026

Important Dates

Impact Assessment

Market impact is high. The combined subdivision and bonus effectively results in each pre-record-date Rs.10 share being replaced by 20 Rs.2 shares (10 from split × 2 from bonus). This significantly increases the floating share count and reduces the per-share price proportionally, which can improve liquidity and retail accessibility. Traders and investors holding Anlon Healthcare shares must note the ISIN change to avoid settlement failures. The new ISIN is yet to be announced, creating a brief operational window where members must wait for the follow-up BSE notice before trading the new shares.

Impact Justification

Dual corporate action (subdivision + bonus) directly affects share count, face value, and ISIN validity for all holders and traders of Anlon Healthcare Ltd from 24 April 2026; existing ISIN INE0Y8W01017 will become invalid for exchange transactions.